Analysis of the central receptors concerned in the cardiovascular response induced by intracerebroventricular aconitine.
D000315:Adrenalectomy; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000470:Alkaloids / Q000494:pharmacology*; D000471:Alkalosis; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001285:Atropine / Q000494:pharmacology; D001919:Bradycardia / Q000139:chemically induced; D002319:Cardiovascular System / Q000187:drug effects*; D002490:Central Nervous System / Q000502:physiology*; D004285:Dogs; D004336:Drug Antagonism; D005260:Female; D006973:Hypertension / Q000139:chemically induced; D007022:Hypotension / Q000139:chemically induced; D008297:Male; D010227:Parabiosis; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D013233:Stellate Ganglion / Q000601:surgery; D013562:Sympathectomy; D009435:Synaptic Transmission; D013610:Tachycardia / Q000139:chemically induced; D014628:Vagotomy; D014666:Vasomotor System / Q000502:physiology; D015016:Yohimbine / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000470:Alkaloids; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D010643:Phenoxybenzamine; D015016:Yohimbine; D001285:Atropine; D011433:Propranolol